SARS-Cov-2 Coronavirus is a new emerging virus causing the COVID-19, a respiratory disease outbreak that started in China in December 2019. On January 30, 2020, the World Health Organization has declared this to be a public health emergency of international concern. By September 2020, COVID-19 has affected more than 33 millionin 210 countries and territories worldwide. In this review, we present an overview of the drugs and medicines to combat COVID-19 currently in the clinical trial. We summarize the challenges facing, and opportunities for the discovery of new therapies in this emergency situation
